...
首页> 外文期刊>Modern Pathology >RT in situ PCR detection of MART-1 and TRP-2 mRNA in formalin-fixed, paraffin-embedded tissues of melanoma and nevi
【24h】

RT in situ PCR detection of MART-1 and TRP-2 mRNA in formalin-fixed, paraffin-embedded tissues of melanoma and nevi

机译:RT原位PCR检测福尔马林固定,石蜡包埋的黑色素瘤和痣组织中MART-1和TRP-2 mRNA

获取原文

摘要

Melanoma antigen recognized by T cells 1 (MART-1) and tyrosinase-related protein-2 (TRP-2) are two useful markers for immunohistochemical detection of melanocytic tumors. However, these markers may be passively acquired (phagocytosed) rather than actively synthesized. Reverse transcriptase in situ polymerase chain reaction (RT in situ PCR) can amplify even small amounts of specific mRNA in cells and therefore confirm the cellular source of a marker. We developed a one-step RT in situ PCR procedure in which Thermus thermophilus DNA polymerase synthesizes and amplifies cDNA from mRNA in a single reaction mixture. To examine its practicability and feasibility with formalin-fixed, paraffin-embedded (FFPE) tissue, we compared the results of one-step RT in situ PCR with those of immunohistochemistry (IHC). MART-1 mRNA was identified in the cytoplasm of lesional cells from 23/26 primary melanomas (92%), 9/9 metastatic melanomas (100%) and 5/6 nevi (83%). MART-1 epitope was detected by IHC in 23/24 primary melanomas (96%), 9/9 metastatic melanomas (100%) and 5/6 nevi (83%). TRP-2 mRNA was identified in the cytoplasm of lesional cells from 17/26 primary melanomas (65%), 6/9 metastatic melanomas (67%) and 4/6 nevi (67%). TRP-2 epitope was detected by IHC in 20/24 primary melanomas (83%), 9/9 metastatic melanomas (100%) and 4/6 nevi (67%). Both techniques detected MART-1 and TRP-2 in FFPE melanoma cell lines. Neither marker was detected in squamous cell carcinomas or basal cell carcinomas by RT in situ PCR or IHC. We conclude that the RT in situ PCR technique can be successfully applied to FFPE tissue to determine the cellular sources of gene expression observed by conventional PCR approaches.
机译:T细胞1(MART-1)和酪氨酸酶相关蛋白2(TRP-2)识别的黑色素瘤抗原是用于免疫组织化学检测黑素瘤的两个有用标记。但是,这些标记可能是被动获取(吞噬),而不是主动合成。逆转录酶原位聚合酶链反应(RT原位PCR)可以扩增细胞中甚至少量的特定mRNA,因此可以确认标记的细胞来源。我们开发了一步式RT原位PCR程序,其中嗜热栖热菌DNA聚合酶在单个反应混合物中合成并扩增来自mRNA的cDNA。为了检查其在福尔马林固定,石蜡包埋(FFPE)组织中的实用性和可行性,我们将一步法RT原位PCR的结果与免疫组织化学(IHC)的结果进行了比较。在23/26例原发性黑色素瘤(92%),9/9转移性黑色素瘤(100%)和5/6痣(83%)的病灶细胞质中鉴定出MART-1 mRNA。 IHC在23/24原发性黑色素瘤(96%),9/9转移性黑色素瘤(100%)和5/6痣(83%)中检测到了MART-1表位。在17/26原发性黑色素瘤(65%),6/9转移性黑色素瘤(67%)和4/6痣(67%)的病灶细胞质中鉴定出TRP-2 mRNA。 IHC在20/24原发性黑色素瘤(83%),9/9转移性黑色素瘤(100%)和4/6痣(67%)中检测到TRP-2表位。两种技术都在FFPE黑色素瘤细胞系中检测到了MART-1和TRP-2。通过RT原位PCR或IHC在鳞状细胞癌或基底细胞癌中均未检测到标记。我们得出结论,RT原位PCR技术可以成功地应用于FFPE组织,以确定通过常规PCR方法观察到的基因表达的细胞来源。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号